These results collectively revealed that USP36 was responsible for the cancer stemness, tumor growth, Oxa-resistance, as well as liver metastasis in colon cancer, which may be a promising therapeutic target for treating patients with colon cancer. This evidence concerns the gene USP36 and malignant colon neoplasm.